Cyclophilin A: A Mediator of Cardiovascular Pathology

참고문헌 (133)

1. Taniyama Y, "Reactive oxygen species in the vasculature: molecular and cellular mechanisms", Hypertension, 42, pp.1075~1081 (2003)
2. Griendling KK, "Redox control of vascular smooth muscle proliferation", Journal of Laboratory and Clinical Medicine, 132, pp.9~15 (1998)
3. Berk BC, "Atheroprotective signaling mechanisms activated by steady laminar flow in endothelial cells", Circulation, 117, pp.1082~1089 (2008)
4. Griendling KK, "Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells", Circulation Research, 74, pp.1141~1148 (1994)
5. Frey RS, "Forum review NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology", Antioxidants & Redox Signaling, 11, pp.791~810 (2009)
6. i through the mitochondrial ROS-PK Cepsilon signaling axis in pulmonary artery smooth muscle cells, "Free Radical Biology & Medicine", 2008, 1223~1231
7. Birukov KG, "Cyclic stretch, reactive oxygen species, and vascular remodeling", Antioxidants & Redox Signaling, 11, pp.1651~1667 (2009)
8. Marks AR, "Cellular functions of immunophilins", Physiological Reviews, 76, pp.631~649 (1996)
9. Ryffel B, "Distribution of the cyclosporine binding protein cyclophilin in human tissues", Immunology, 72, pp.399~404 (1991)
10. Handschumacher RE, "Cyclophilin: a specific cytosolic binding protein for cyclosporin A", Science, 226, pp.544~547 (1984)
11. Takahashi N, "Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin", Nature, 337, pp.473~475 (1989)
12. Schreiber SL, "Chemistry and biology of the immunophilins and their immunosuppressive ligands", Science, 251, pp.283~287 (1991)
13. Zhu C, "Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia", The Journal of Experimental Medicine, 204, pp.1741~1748 (2007)
14. Brazin KN, "Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A", Proceedings of the National Academy of Sciences, 99, pp.1899~1904 (2002)
15. Colgan J, "Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk", Immunity, 21, pp.189~201 (2004)
16. Krummrei U, "Cyclophilin-A is a zinc-dependent DNA binding protein in macrophages", FEBS Letters, 371, pp.47~51 (1995)
17. Walter DH, "Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria", Circulation, 98, pp.1153~1157 (1998)
18. Jonasson L, "Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury", Proceedings of the National Academy of Sciences, 85, pp.2303~2306 (1988)
19. Gregory CR, "Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement", Transplantation, 59, pp.655~661 (1995)
20. Andersen HO, "Effect of cyclosporine on arterial balloon injury lesions in cholesterol-clamped rabbits: T lymphocyte- mediated immune responses not involved in balloon injury-induced neointimal proliferation", Arteriosclerosis, Thrombosis, and Vascular Biology, 19, pp.1687~1694 (1999)
21. Ferns G, "Vascular effects of cyclosporine A in vivo and in vitro", American Journal of Pathology, 137, pp.403~413 (1990)
22. Jin ZG, "Cyclophilin A is a proinflammatory cytokine that activates endothelial cells", Arteriosclerosis, Thrombosis, and Vascular Biology, 24, pp.1186~1191 (2004)
23. Jin ZG, "Cyclophilin A is a secreted growth factor induced by oxidative stress", Circulation Research, 87, pp.789~796 (2000)
24. Satoh K, "Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation", Circulation, 117, pp.3088~3098 (2008)
25. Sun J, "Regulation of MMP-1 and MMP-2 production through CD147", extracellular matrix metalloproteinase inducer interactions, 2001, pp.61, 2276~2281
26. Pushkarsky T, "CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A", Proceedings of the National Academy of Sciences USA, 98, pp.6360~6365 (2001)
27. Damsker JM, "Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A", Journal of Leukocyte Biology, 82, pp.613~618 (2007)
28. Asea A, "HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine", Nature Medicine, 6, pp.435~442 (2000)
29. Pakula R, "Syndecan-1", CD147 association is essential for cyclophilin B-induced activation of p44, Glycobiology, pp.2007, 17[DOI]
30. Hanoulle X, "Wieruszeski JM, et al. Structural and functional characterization of the interaction between Cyclophilin B and a heparin-derived oligosaccharide", The Journal of Biological Chemistry, 282, pp.34148~34158 (2007)
31. Binder RJ, "CD91: a receptor for heat shock protein gp96", Nature Immunology, 1, pp.151~155 (2000)
32. Pushkarsky T, "CD147 stimulates HIV-1 infection in a signal-independent fashion", Biochemical and Biophysical Research Communications, 363, pp.495~499 (2007)
33. Suzuki J, "Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells", Circulation Research, 98, pp.811~817 (2006)
34. Colgan J, "Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine", Journal of Immunology, 174, pp.6030~6038 (2005)
35. Miller AT, "Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet", Immunity, 21, pp.67~80 (2004)
36. Zhou X, "Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice", American Journal of Pathology, 149, pp.359~366 (1996)
37. Hansson GK, "Inflammation, atherosclerosis, and coronary artery disease", The New England Journal of Medicine, 352, pp.1685~1695 (2005)
38. Xu Q, "Role of heat shock proteins in atherosclerosis", Arteriosclerosis, Thrombosis, and Vascular Biology, 22, pp.1547~1559 (2002)
39. Al-Daraji WI, "Localization of calcineurin", NFAT in human skin and psoriasis and inhibition of calcineurin, Journal of Investigative Dermatology, pp.2002, 118[DOI]
40. Arevalo-Rodriguez M, "Cyclophilin A is localized to the nucleus and controls meiosis in Saccharomyces cerevisiae", Eukaryotic Cell, 4, pp.17~29 (2005)
41. Pan H, "Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2, activation and nuclear translocation of ERK1", 2, and chemotactic cell migration, 2008, pp.283, 623~637
42. Sherry B, "Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages", Proceedings of the National Academy of Sciences USA, 89, pp.3511~3515 (1992)
43. Rietschel ET, "Samalouti V, Mattern T, Zahringer U, et al. Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation", Microbial Drug Resistance, 4, pp.37~44 (1998)
44. Fujihara M, "Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex", Pharmacology & Therapeutics, 100, pp.171~194 (2003)
45. Billich A, "Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis", Journal of Experimental Medicine, 185, pp.975~980 (1997)
46. Tegeder I, "Elevated serum cyclophilin levels in patients with severe sepsis", Journal of Clinical Immunology, 17, pp.380~386 (1997)
47. Endrich MM, "The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood", European Journal of Biochemistry, 252, pp.441~446 (1998)
48. Liao DF, "Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells", Journal of Biological Chemistry, 275, pp.189~196 (2000)
49. Baas AS, "Differential activation of mitogen- activated protein kinases by H2O2 and O2- in vascular smooth muscle cells", Circulation Research, 77, pp.29~36 (1995)
50. Meloche S, "Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity", Molecular Endocrinology, 6, pp.845~854 (1992)
51. York RD, "Eckert SP, McCleskey EW, et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor", Nature, 392, pp.622~626 (1998)
52. Zafari AM, "Role of NADH", NADPH oxidase- derived H2O2 in angiotensin II-induced vascular hypertrophy, 1998, pp.32, 488~495
53. Rajagopalan S, "Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH", NADPH oxidase activation. Contribution to alterations of vasomotor tone, 1996, pp.97, 1916~1923
54. Nat Med. Satoh K, "Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms", Nature Medicine, 15, pp.649~656 (2009)
55. Takapoo M, "Glutathione peroxidase-deficient smooth muscle cells cause paracrine activation of normal smooth muscle cells via cyclophilin A", Vascular Pharmacology, 55, pp.143~148 (2011)
56. 김세화, "Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction", AMERICAN JOURNAL OF PATHOLOGY, 164(5), pp.1567~1574, AMER SOC INVESTIGATIVE PATHOLOGY
57. Seko Y, "Hypoxia and hypoxia", reoxygenation activate Raf-1, mitogen- activated protein kinase kinase, mitogen-activated protein kinases, and S6 kinase in cultured rat cardiac myocytes, 1996, pp.78, 82~90
58. Seko Y, "Hypoxia and hypoxia", reoxygenation activate Src family tyrosine kinases and p21ras in cultured rat cardiac myocytes, 1996, pp.226, 530~535
59. Satoh K, "Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice", Arteriosclerosis, Thrombosis, and Vascular Biology, 31, pp.1116~1123 (2011)
60. Fratelli M, "Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes", Proceedings of the National Academy of Sciences USA, 99, pp.3505~3510 (2002)
61. Ghezzi P, "Redox regulation of cyclophilin A by glutathionylation", Proteomics, 6, pp.817~825 (2006)
62. Massignan T, "Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse", Biochemical and Biophysical Research Communications, 353, pp.719~725 (2007)
63. Lammers M, "Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerization", Nature Chemical Biology, 6, pp.331~337 (2010)
64. Bryant SR, "Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2", Circulation Research, 84, pp.323~328 (1999)
65. Chiang HY, "Fibronectin is an important regulator of flow-induced vascular remodeling", Arteriosclerosis, Thrombosis, and Vascular Biology, 29, pp.1074~1079 (2009)
66. Acevedo L, "A new role for Nogo as a regulator of vascular remodeling", Nature Medicine, 10, pp.382~388 (2004)
67. Carmeliet P, "Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice", Circulation Research, 81, pp.829~839 (1997)
68. Filippov S, "MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells", Journal of Experimental Medicine, 202, pp.663~671 (2005)
69. Hassan GS, "Caveolin-1 deficiency stimulates neointima formation during vascular injury", Biochemistry, 43, pp.8312~8321 (2004)
70. Korshunov VA, "Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening", Arteriosclerosis, Thrombosis, and Vascular Biology, 23, pp.2185~2191 (2003)
71. Korshunov VA, "Strain-dependent vascular remodeling: the "Glagov phenomenon" is genetically determined", Circulation, 110, pp.220~226 (2004)
72. Ruef J, "Induction of vascular endothelial growth factor in balloon- injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis", Circulation Research, 81, pp.24~33 (1997)
73. Ruef J, "Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury", Arteriosclerosis, Thrombosis, and Vascular Biology, 20, pp.1745~1752 (2000)
74. Leite PF, "Sustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits", Arteriosclerosis, Thrombosis, and Vascular Biology, 23, pp.2197~2202 (2003)
75. Hsieh HJ, "Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression", Journal of Cellular Physiology, 175, pp.156~162 (1998)
76. Castier Y, "p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling", Circulation Research, 97, pp.533~540 (2005)
77. Castier Y, "Role of NF-kappaB in flow-induced vascular remodeling", Antioxidants & Redox Signaling, 11, pp.1641~1649 (2009)
78. Menshikov M, "Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redox-dependent pathways", Arteriosclerosis, Thrombosis, and Vascular Biology, 26, pp.801~807 (2006)
79. Seki Y, "Role of the JAK", STAT pathway in rat carotid artery remodeling after vascular injury, 2000, pp.87, 12~18
80. Lambert CM, "Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases", American Journal of Physiology - Heart and Circulatory Physiology, 299, pp.995~1001 (2010)
81. El Mabrouk M, "Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR", American Journal of Physiology - Heart and Circulatory Physiology, 281, pp.30~39 (2001)
82. Paravicini TM, "Redox signaling in hypertension", Cardiovascular Research, 71, pp.247~258 (2006)
83. Berk BC, "Redox signals that regulate the vascular response to injury", Thrombosis and Haemostasis, 82, pp.810~817 (1999)
84. Touyz RM, "Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells", Journal of Hypertension, 19, pp.441~449 (2001)
85. Ishida M, "Activation of extracellular signal-regulated kinases (ERK1", 2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells, 1998, pp.82, 7~12
86. Saito Y, "Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation", Molecular and Cellular Biology, 21, pp.6387~6394 (2001)
87. Yang H, "Effects of cyclophilin A on cell proliferation and gene expressions in human vascular smooth muscle cells and endothelial cells", Journal of Surgical Research, 123, pp.312~319 (2005)
88. Yang Y, "Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes", macrophages via CD147 signalling pathway in rheumatoid arthritis, 2008, pp.47, 1299~1310
89. Yurchenko V, "Active site residues of cyclophilin A are crucial for its signaling activity via CD147", Journal of Biological Chemistry, 277, pp.22959~22965 (2002)
90. Obchoei S, "Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma", Molecular Cancer, 10, pp.102~ (2011)
91. Yang H, "Cyclophilin A is upregulated in small cell lung cancer and activates ERK1", 2 signal, 2007, pp.361, 763~767
92. Li M, "Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147", Cancer, 106, pp.2284~2294 (2006)
93. Artus C, "AIF promotes chromatinolysis and caspase- independent programmed necrosis by interacting with histone H2AX", EMBO Journal, 29, pp.1585~1599 (2010)
94. Elbaz B, "Cyclophilin A is involved in functional expression of the Na(+)-Ca(2+) exchanger NCX1", Biochemistry, 49, pp.7634~7642 (2010)
95. Gerthoffer WT, "Mechanisms of vascular smooth muscle cell migration", Circulation Research, 100, pp.607~621 (2007)
96. Xu Q, "Handschumacher RE, Lyttle CR. Leukocyte chemotactic activity of cyclophilin", Journal of Biological Chemistry, 267, pp.11968~11971 (1992)
97. Wang L, "Contribution of cyclophilin A to the regulation of inflammatory processes in rheumatoid arthritis", Journal of Clinical Immunology, 30, pp.24~33 (2010)
98. Daugherty A, "Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice", Journal of Clinical Investigation, 105, pp.1605~1612 (2000)
99. Feldman DS, "Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminus", Journal of Biological Chemistry, 277, pp.28631~28640 (2002)
100. Alexis JD, "Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells", Circulation Research, 104, pp.69~78 (2009)
101. McCormick ML, "Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms", Arteriosclerosis, Thrombosis, and Vascular Biology, 27, pp.461~469 (2007)
102. Bruemmer D, "Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice", Journal of Clinical Investigation, 112, pp.1318~1331 (2003)
103. Pyo R, "Targeted gene disruption of matrix metalloproteinase- 9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms", Journal of Clinical Investigation, 105, pp.1641~1649 (2000)
104. Longo GM, "Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms", Journal of Clinical Investigation, 110, pp.625~632 (2002)
105. Visse R, "Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry", Circulation Research, 92, pp.827~839 (2003)
106. Aartsen WM, "Changes in vascular distensibility during angiotensin-converting enzyme inhibition involve bradykinin type 2 receptors", Journal of Vascular Research, 41, pp.18~27 (2004)
107. Police SB, "Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation", Arteriosclerosis, Thrombosis, and Vascular Biology, 29, pp.1458~1464 (2009)
108. Browatzki M, "Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner", Journal of Vascular Research, 42, pp.415~423 (2005)
109. Luchtefeld M, "Angiotensin II induces MMP-2 in a p47phox-dependent manner", Biochemical and Biophysical Research Communications, 328, pp.183~188 (2005)
110. Rajagopalan S, "Reactive oxygen species produced by macrophage- derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability", Journal of Clinical Investigation, 98, pp.2572~2579 (1996)
111. Hansson GK, "The immune response in atherosclerosis: a double-edged sword", Nature Reviews Immunology, 6, pp.508~519 (2006)
112. Libby P, "Inflammation in atherosclerosis", Nature, 420, pp.868~874 (2002)
113. Ross R, "Atherosclerosis--an inflammatory disease", The New England Journal of Medicine, 340, pp.115~126 (1999)
114. Weber C, "The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models", Nature Reviews Immunology, 8, pp.802~815 (2008)
115. Rahman A, "E-selectin expression in human endothelial cells by TNF-alpha- induced oxidant generation and NF-kappaB activation", American Journal of Physiology, 275, pp.L533~544 (1998)
116. Tricot O, "Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques", Circulation, 101, pp.2450~2453 (2000)
117. Ostergaard L, "Proteomics reveals lowering oxygen alters cytoskeletal and endoplasmatic stress proteins in human endothelial cells", Proteomics, 9, pp.4457~4467 (2009)
118. Nigro P, "Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice", Journal of Experimental Medicine, 208, pp.53~66 (2011)
119. Izumo S, "Calcineurin--the missing link in cardiac hypertrophy", Nature Medicine, 4, pp.661~662 (1998)
120. Mehta PK, "Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system", American Journal of Physiology - Cell Physiology, 292, pp.C82~97 (2007)
121. Sadoshima J, "Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype", Circulation Research, 73, pp.413~423 (1993)
122. Nakamura K, "Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II", Circulation, 98, pp.794~799 (1998)
123. Akki A, "NADPH oxidase signaling and cardiac myocyte function", Journal of Molecular and Cellular Cardiology, 47, pp.15~22 (2009)
124. Takimoto E, "Role of oxidative stress in cardiac hypertrophy and remodeling", Hypertension, 49, pp.241~248 (2007)
125. Weber KT, "Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system", Circulation, 83, pp.1849~1865 (1991)
126. Yellon DM, "Hausenloy DJ. Myocardial reperfusion injury", The New England Journal of Medicine, 357, pp.1121~1135 (2007)
127. Turer AT, "Pathogenesis of myocardial ischemia- reperfusion injury and rationale for therapy", American Journal of Cardiology, 106, pp.360~368 (2010)
128. Prasad A, "Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion", Circulation, 120, pp.2105~2112 (2009)
129. Hess ML, "Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia", reperfusion injury, 1984, pp.16, 969~985
130. Becker LB, "New concepts in reactive oxygen species and cardiovascular reperfusion physiology", Cardiovascular Research, 61, pp.461~470 (2004)
131. Braunersreuther V, "Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches", Current Pharmaceutical Biotechnology (2011)
132. Otani H, "The role of nitric oxide in myocardial repair and remodeling", Antioxidants & Redox Signaling, 11, pp.1913~1928 (2009)
133. Seizer P, "Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion", Biochemical and Biophysical Research Communications, 31, pp.1377~1386 (2011)

관련 논문AI추천